Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Affective Disorders
|
November 1, 1990
Fluoxetine in tricyclic refractory major depressive disorder
C M Beasley, M E Sayler, G E Cunningham, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
Depression and Anxiety
|
January 1, 1997
Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior
J F Wernicke, M E Sayler, S C Koke, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1994
Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine
G D Tollefson, J H Greist, J W Jefferson, et al.
Obesity Research
|
November 1, 1995
Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success
D J Goldstein, A H Rampey, P J Roback, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
December 1, 1993
Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders
G D Tollefson, J Fawcett, G Winokur, et al.
BMJ (Clinical Research Ed.)
|
October 1, 1991
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression
C M Beasley, B E Dornseif, J C Bosomworth, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Affective Disorders
|
November 1, 1990
Fluoxetine in tricyclic refractory major depressive disorder
C M Beasley, M E Sayler, G E Cunningham, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
Depression and Anxiety
|
January 1, 1997
Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior
J F Wernicke, M E Sayler, S C Koke, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1994
Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine
G D Tollefson, J H Greist, J W Jefferson, et al.
Obesity Research
|
November 1, 1995
Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success
D J Goldstein, A H Rampey, P J Roback, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
December 1, 1993
Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders
G D Tollefson, J Fawcett, G Winokur, et al.
BMJ (Clinical Research Ed.)
|
October 1, 1991
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression
C M Beasley, B E Dornseif, J C Bosomworth, et al.
Page
of 2